Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2018

View Archived Issues

Kinase interplay prevents ALS

Parkin, PINK keep inflammation pout of the red zone

Brain-on-three-chips includes BBB

Unexpected asthma mechanism changes targeting calculus

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

University of Michigan describes bromodomain and extra-terminal protein inhibitors

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

G-0775: An arylomycin class Gram-negative antibiotic

Zai Lab discontinues development of ZL-3101 for atopic dermatitis

European Commission approves Vyxeos for two types of high-risk AML

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

European Commission approves Kymriah

Yescarta approved in E.U. for relapsed or refractory DLBCL and PMBCL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...